Oct 5, 2020 12:57 PM ET
iCrowd Newswire – Oct 5, 2020
Zion Market Research has published a new report titled “Calcitriol Market by Product Type (Calcitriol Capsule, Calcitriol Solution, and Others), by Application (Osteoporosis, Renal Osteodystrophy, and Others), and by Distribution Channel (Direct Sales and Distributor): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2024”. According to the report, the global calcitriol market was valued at approximately USD 350 million in 2017 and is expected to generate revenue of around USD 470 million by 2024, growing at a CAGR of around 4.3% between 2018 and 2024.
Calcitriol is an active form of vitamin D, which is found in the human body. It is normally produced in the kidneys through the conversion of 25-hydroxycholecalciferol into 25-hydroxyvitamin D-1 a-hydroxylase. A deficiency of vitamin D might lead to various health conditions, such as osteoporosis, which affects the production of parathyroid hormone, among other bone-related diseases. To avoid such conditions, vitamin D is consumed in the form of tablets, which have calcitriol in their composition. It regulates the normal function of the human body by maintaining the body’s calcium level along with increasing the absorption of calcium and phosphate in the gastrointestinal tract. Calcitriol is mainly used for the treatment of hypocalcemia and osteoporosis. Calcitriol usually does not have any side effects, but patients often complain of dry-mouth, vomiting, constipation, headache, minor abnormalities in the kidneys, abdominal pain, nausea, muscle pain, etc.
Get PDF Sample Copy of this Report to understand the structure of the complete report @ https://www.zionmarketresearch.com/sample/calcitriol-market/news
There are various factors driving the growth of the calcitriol market, which includes the increased prevalence of osteoporosis and other bone-related diseases, increase in renal osteodystrophy, etc. Osteoporosis leads to weak bones, making them more prone to fractures. As per the International Osteoporosis Foundation, around 8.9 million fractures annually are caused due to osteoporosis worldwide and increasing prevalence leads to the increased calcitriol demand. Moreover, the increasing awareness among people and growth in the healthcare infrastructure along with technological advancements are expected to further propel the calcitriol market in the upcoming years. Furthermore, the increasing prevalence of hypoparathyroidism is also a major factor driving the calcitriol market. However, the stringent regulatory process and intellectual property rights might inhibit the calcitriol market growth over the forecast time period. Moreover, the expiry of branded drugs and increased investments made in the research and development of new drugs are expected to create new opportunities in the calcitriol market over the estimated time period.
Calcitriol market is classified based on product type, application, and distribution channel. By product type, the calcitriol market is segmented into calcitriol capsule, calcitriol solution, and others. The calcitriol solution segmented is likely to grow rapidly over the forecast time period. By application, the calcitriol market is categorized into osteoporosis, renal osteodystrophy, and others. Renal osteodystrophy is likely to grow rapidly over the forecast time period. By distribution channel, the calcitriol market is bifurcated into direct sales and distributor. The direct sales channel is expected to dominate the calcitriol market in the future.
North America is expected to dominate the calcitriol market over the forecast period due to the increased prevalence of osteoporosis and other bone-related disorders in the region. Moreover, the presence of developed countries, such as the U.S. and Canada, and the presence of developed healthcare infrastructure are also expected to support this market. Europe is expected to be the second largest developing market over the forecast period and closely follow North America in terms of revenue. The Asia Pacific is anticipated to develop rapidly over the forecast time period, owing to the presence of developing economies, such as India and China. Moreover, the presence of developing healthcare infrastructure and increased prevalence of bone-related disorders are expected to promote the growth of the calcitriol market over the estimated timeframe. Latin America and the Middle East and Africa are expected to develop considerably in this market.
Some of the major players of the calcitriol market include F. Hoffmann-La Roche Ltd., Sun Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals, Akorn, Incorporated, Strides Pharma Science Limited, and Amneal Pharmaceuticals LLC, among others.
This report segments the global calcitriol market as follows:
Global Calcitriol Market: Product Type Segment Analysis
- Calcitriol Capsule
- Calcitriol Solution
Global Calcitriol Market: Application Segment Analysis
- Renal Osteodystrophy
Global Calcitriol Market: Distribution Channel Segment Analysis
- Direct Sales
Global Calcitriol Market: Regional Segment Analysis
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
You can Buy This Report from Here @ https://www.zionmarketresearch.com/buynow/su/calcitriol-market/news
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: [email protected]
Keywords: Calcitriol Market